Psychedelic Industry Revolution

According to a Harvard study, the medical cost of mental health is projected to increase to $6 trillion by 2030. A Research and Markets report also estimates the psychedelic drugs market to expand at a robust rate of 14.5% between 2021 and 2026 and will double in value from around $6.3 billion in 2026 from $3.2 billion in 2021. Moreover, the same report anticipates depression to dominate the mental disorder conditions as it has a more than 40% market share in 2021.